G. Zimmermann

Molecular Biology · Drug Discovery Today · 2003–2009

A researcher in the Science corpus: 3 papers; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

Whom G. Zimmermann trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. W. Kaelin

Who trusts G. Zimmermann overall

  1. Hui Huang
  2. Joseph Lehar
  3. Julie Foucquier
  4. Ping Zhang
  5. Shao Li
  6. A. Hopkins

Papers from G. Zimmermann's perspective

Ordered by how strongly the researchers G. Zimmermann trusts endorse each paper. Same corpus, a different order for every researcher.

  1. The Concept of Synthetic Lethality in the Context of Anticancer Therapy (Nature Reviews. Cancer)
  2. Multi-target therapeutics: when the whole is greater than the sum of the parts. (Drug Discovery Today)
  3. Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR (Proceedings of the National Academy of Sciences of the United States of America)
  4. Targeting HIF-1 for cancer therapy (Nature Reviews. Cancer)
  5. Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1 (Science)
  6. [Serial analysis of gene expression]. (Yi chuan = Hereditas)
  7. The PIK3CA gene is mutated with high frequency in human breast cancers (Cancer Biology & Therapy)
  8. Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer (Nature Medicine)
  9. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. (Cell)
  10. Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. (Molecules and Cells)

Their papers